New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies

A new series of benzoxazole derivatives were designed and synthesised to have the main essential pharmacophoric features of VEGFR-2 inhibitors. Cytotoxic activities were evaluated for all derivatives against two human cancer cell lines, MCF-7 and HepG2. Also, the effect of the most cytotoxic derivat...

Full description

Saved in:
Bibliographic Details
Main Authors: Hazem Elkady (Author), Alaa Elwan (Author), Hesham A. El-Mahdy (Author), Ahmed S. Doghish (Author), Ahmed Ismail (Author), Mohammed S. Taghour (Author), Eslam B. Elkaeed (Author), Ibrahim H. Eissa (Author), Mohammed A. Dahab (Author), Hazem A. Mahdy (Author), Mohamed M. Khalifa (Author)
Format: Book
Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_67393c5d353040d2a6882e7cf732c5b3
042 |a dc 
100 1 0 |a Hazem Elkady  |e author 
700 1 0 |a Alaa Elwan  |e author 
700 1 0 |a Hesham A. El-Mahdy  |e author 
700 1 0 |a Ahmed S. Doghish  |e author 
700 1 0 |a Ahmed Ismail  |e author 
700 1 0 |a Mohammed S. Taghour  |e author 
700 1 0 |a Eslam B. Elkaeed  |e author 
700 1 0 |a Ibrahim H. Eissa  |e author 
700 1 0 |a Mohammed A. Dahab  |e author 
700 1 0 |a Hazem A. Mahdy  |e author 
700 1 0 |a Mohamed M. Khalifa  |e author 
245 0 0 |a New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies 
260 |b Taylor & Francis Group,   |c 2022-12-01T00:00:00Z. 
500 |a 1475-6366 
500 |a 1475-6374 
500 |a 10.1080/14756366.2021.2015343 
520 |a A new series of benzoxazole derivatives were designed and synthesised to have the main essential pharmacophoric features of VEGFR-2 inhibitors. Cytotoxic activities were evaluated for all derivatives against two human cancer cell lines, MCF-7 and HepG2. Also, the effect of the most cytotoxic derivatives on VEGFR-2 protein concentration was assessed by ELISA. Compounds 14o, 14l, and 14b showed the highest activities with VEGFR-2 protein concentrations of 586.3, 636.2, and 705.7 pg/ml, respectively. Additionally, the anti-angiogenic property of compound 14b against human umbilical vascular endothelial cell (HUVEC) was performed using a wound healing migration assay. Compound 14b reduced proliferation and migratory potential of HUVEC cells. Furthermore, compound 14b was subjected to further biological investigations including cell cycle and apoptosis analyses. Compound 14b arrested the HepG2 cell growth at the Pre-G1 phase and induced apoptosis by 16.52%, compared to 0.67% in the control (HepG2) cells. The effect of apoptosis was buttressed by a 4.8-fold increase in caspase-3 level compared to the control cells. Besides, different in silico docking studies were also performed to get better insights into the possible binding mode of the target compounds with VEGFR-2 active sites. 
546 |a EN 
690 |a anti-proliferative 
690 |a apoptosis 
690 |a benzoxazole 
690 |a vegfr-2 inhibitors 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 403-416 (2022) 
787 0 |n http://dx.doi.org/10.1080/14756366.2021.2015343 
787 0 |n https://doaj.org/toc/1475-6366 
787 0 |n https://doaj.org/toc/1475-6374 
856 4 1 |u https://doaj.org/article/67393c5d353040d2a6882e7cf732c5b3  |z Connect to this object online.